Your browser doesn't support javascript.
loading
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients.
Würnschimmel, Christoph; Collà Ruvolo, Claudia; Nocera, Luigi; Wenzel, Mike; Tian, Zhe; Saad, Fred; Briganti, Alberto; Shariat, Shahrokh F; Mirone, Vincenzo; Chun, Felix K H; Tilki, Derya; Graefen, Markus; Karakiewicz, Pierre I.
Afiliación
  • Würnschimmel C; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada. Electronic address: c.wuernschimmel@gmail.com.
  • Collà Ruvolo C; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Nocera L; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCSS San Raffaele Scientific Institute, Milan, Italy; Department of Urology, University Hospital Hamburg-Eppendorf, Germany.
  • Wenzel M; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Tian Z; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
  • Saad F; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
  • Briganti A; Department of Urology and Division of Experimental Oncology, URI, Urological Research Institute, IRCSS San Raffaele Scientific Institute, Milan, Italy.
  • Shariat SF; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Departments of Urology, Weill Cornell Medical College, New York, NY, USA; Department of Urology, University of Texas Southwestern, Dallas, TX, USA; Department of Urology, Second Faculty of Medicine, Ch
  • Mirone V; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Chun FKH; Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany.
  • Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Graefen M; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Karakiewicz PI; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.
Eur Urol Focus ; 8(1): 191-199, 2022 Jan.
Article en En | MEDLINE | ID: mdl-33610487

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Esperanza de Vida / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Límite: Female / Humans / Male Idioma: En Revista: Eur Urol Focus Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Esperanza de Vida / Neoplasias Renales Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Determinantes_sociais_saude / Patient_preference Límite: Female / Humans / Male Idioma: En Revista: Eur Urol Focus Año: 2022 Tipo del documento: Article
...